← The Wire
CHENYSE
CHEMED CORP
Services-Home Health Care Services · DE · CIK 19584
Chemed purchases, operates, and divests subsidiaries in diverse businesses, including hospice care and plumbing services
$5.57B
Market cap
$459.90
Last close
-0.7%
1D
+5.5%
5D
117K
Volume
Price · last 39 sessions+8.0%
May 4L $417.21 · H $463.28Jun 29
191
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
11-K11-KJun 24, 20268-KShareholder VoteMay 19, 202610-Q10-QApr 28, 20268-KResults of OperationsApr 23, 20268-KMaterial Agreement · New Debt / ObligationApr 13, 2026DEF 14ADEF 14AApr 6, 202610-KFORM 10-KFeb 27, 20268-KResults of OperationsFeb 25, 202610-Q10-QOct 31, 20258-KResults of OperationsOct 28, 202510-Q10-QJul 31, 20258-KExecutive Change · Results of OperationsJul 29, 20258-KReg FD DisclosureJun 27, 202511-K11-KJun 27, 20258-KShareholder VoteMay 20, 202510-Q10-QApr 28, 20258-KResults of OperationsApr 23, 2025DEF 14ADEF 14AApr 7, 202510-K/A10-K/AApr 1, 202510-K10-KFeb 28, 20258-KResults of OperationsFeb 26, 202510-Q10-QNov 1, 20248-KResults of OperationsOct 29, 202410-Q10-QJul 26, 20248-KResults of OperationsJul 24, 202411-K11-KJun 26, 20248-KShareholder VoteMay 21, 202410-Q10-QApr 29, 20248-KResults of OperationsApr 24, 20248-KAcquisition / DispositionApr 17, 2024DEF 14ADEF 14AApr 8, 20248-KCompany UpdateMar 13, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 27, 20248-KExecutive ChangeFeb 1, 20248-KExecutive ChangeDec 18, 20238-KExecutive ChangeNov 3, 202310-Q10-QOct 27, 20238-KResults of OperationsOct 25, 202310-Q10-QJul 28, 20238-KResults of OperationsJul 26, 202311-K11-KJun 28, 20238-KShareholder VoteMay 16, 202310-Q10-QApr 28, 20238-KResults of OperationsApr 26, 2023DEF 14ADEF 14AApr 6, 202310-K10-KFeb 27, 20238-KResults of OperationsFeb 23, 2023SC 13GSC 13GJan 24, 20238-KBylaw AmendmentDec 9, 20228-K/AExecutive ChangeNov 7, 202210-Q10-QNov 2, 20228-KResults of OperationsOct 31, 20228-KExecutive ChangeAug 5, 202210-Q10-QJul 29, 20228-KResults of OperationsJul 27, 20228-KMaterial Agreement · New Debt / ObligationJun 29, 202211-KCHEMED CORPORATION 11-KJun 23, 20228-KShareholder VoteMay 17, 202210-Q10-QApr 29, 20228-KResults of OperationsApr 26, 2022DEF 14ACHEMED CORPORATION DEF 14AApr 8, 202210-K10-KFeb 28, 20228-KResults of OperationsFeb 24, 202210-Q10-QNov 1, 20218-KResults of OperationsOct 28, 202110-Q10-QJul 30, 20218-KResults of OperationsJul 27, 202111-KCHEMED CORPORATION 11-KJun 17, 20218-KShareholder VoteMay 19, 202110-Q10-QApr 30, 20218-KResults of OperationsApr 27, 2021DEF 14ACHEMED CORP. DEF 14AApr 9, 202110-K10-KFeb 26, 20218-KResults of OperationsFeb 23, 202110-Q10-QNov 4, 20208-KResults of OperationsOct 29, 20208-KExecutive ChangeSep 1, 202010-Q10-QJul 31, 20208-KResults of OperationsJul 30, 2020
Insider Activity
In the 90 days to Mar 27, 2026: 1 sold $1.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Mcnamara Kevin Jpresident and CEO | Sell | 1,500 | $369.37 | $554K |
| Mar 12, 2026 | Mcnamara Kevin Jpresident and CEO | Sell | 2,000 | $403.18 | $806K |
| Nov 24, 2025 | Mcnamara Kevin Jpresident and CEO | Sell | 2,000 | $437.55 | $875K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
What Changed
Risk factors · Feb 28, 2025 → Feb 27, 202628 added · 14 removed between the two most recent 10-Ks. The risks a company starts — or stops — disclosing are often the story.
Newly disclosed
- Despite significant safeguards, including active intrusion protection, firewalls and virus detection software, as discussed in greater detail on Item 1C below, in October of 2025, access to our systems was gained by a threat actor in a cybersecurity attack.
- Also, effective marketing and advertising may become more expensive and more difficult as search engines revise algorithms, customers use of artificial intelligence (“AI”) platforms become more prevalent and business models and customers change how they find our services.
- The current environment, particularly in 18 healthcare and with the increase in use of AI and other new technologies, has significantly increased our usage of information technology systems and heightened the need for security of those systems with the increase in telehealth.
- Additionally, because our service businesses heavily rely on delivering service to customers or patients in their residences, increases in the costs of vehicle acquisition, maintenance, repair, and reimbursement for employees’ use of personal vehicles, could have a significant increase on our expenses.
- The threat actor was able to access a significant amount of Protected Health Information (“PHI”); however, despite repeated attempts, was not able to insert a tool often used by threat actors into our system.
- Although the cyberattack that led to the breach of PHI was the first to successfully gain access to our systems, it was not an isolated incident.
- Additionally, the increasing development and use of AI and other new and evolving technologies create additional system and other risks.
- VITAS’ levels of revenue and profitability will be subject to the effect of possible reductions in coverage or payment rates by third-party payors, including payment rates from Medicare and Medicaid. 14 Hospice Medicare reimbursement is subject to certain limitations or “caps” based on the number of inpatient days of care and overall average capitation per admission.
- While we have been able to mitigate the damages from the prior successful attack, and did not experience any material operational or financial issues as a result of the attack, a subsequent successful attack on our information technology systems could have even greater consequences to the business including liability for compromised patient information and business interruption.
- However, if CMS revises the program or implements a similar program and its implementation identifies any VITAS programs as “poor performers”, such designation could negatively affect VITAS’ brand reputation, and any additional governmental oversight could materially adversely affect the operations profitability of any affected programs.
- These additional costs, in the case of VITAS, cannot be passed along to our patients because of the structure of hospice reimbursement, and in the case of Roto-Rooter, may not be able to be fully passed along to our customers.
- To the extent that tariffs cause any adverse impacts on global supply chains, it could further materially affect the ability of both businesses to timely source critical supplies, which may affect our delivery of services.
No longer disclosed
- We maintain our information technology systems with safeguard protection against cyber-attacks including active intrusion protection, firewalls and virus detection software.
- We have developed and tested a response plan in the event of a successful attack and we maintain commercial insurance related to a cyber-attack.
- Chemed’s Chief Legal Officer and Chief Financial Officer are alerted to any potential issues and evaluate those issues for cybersecurity materiality A successful attack on our information technology systems could have significant consequences to the business including liability for compromised patient information and business interruption.
- However, if CMS revises the program and its reimplementation identifies any VITAS programs as “poor performers”, such designation could negatively affect VITAS’ brand reputation, and any additional governmental oversight could materially adversely affect the operations profitability of any affected programs. 18 VITAS’ headquarters and a significant portion of its operations are in Florida The occurrence of a natural disaster in any region that VITAS has significant operations could have a negative impact on the business.
- Increases in working from home and the provision of telehealth services due to the pandemic have significantly increased our usage of information technology systems and heightened the need for security of those systems.
- VITAS’ levels of revenue and profitability will be subject to the effect of possible reductions in coverage or payment rates by third-party payors, including payment rates from Medicare and Medicaid.
- VITAS’ loss of key management personnel or its inability to hire and retain skilled employees could adversely affect its business, financial condition and results of operations.
- Hospice Medicare reimbursement is subject to certain limitations or “caps” based on the number of inpatient days of care and overall average capitation per admission.
- We depend on our management team and the loss of their service could have a material adverse effect on our business, financial condition and results of operations.
- Credit market conditions may make it difficult for us to obtain new financing or refinance our current debt on terms and conditions acceptable to us.
- Moreover, we cannot assure you that awareness or acceptance of hospice care will increase or remain at current levels.
- Changes in rates or methods of payment for VITAS’ services could adversely affect its revenues and profits.
Similar companies
Comparable business profile · signals at a glance